Carol J. Wikstrand

9.5k citations

105 papers · 7.5k indexed · 1 hit paper · h-index 48

Genetics top 0.2%
- Glioma Diagnosis and Treatment 17
Oncology top 0.5%
- HER2/EGFR in Cancer Research 13
Immunology and Allergy top 1%
- Cell Adhesion Molecules Research 11
Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research 39
- Radiopharmaceutical Chemistry and Applications 28
Immunology top 1%
- Immunotherapy and Immune Responses 18
Molecular Biology
- Glycosylation and Glycoproteins Research 26
Neurology
- Neuroblastoma Research and Treatments 24

Co-authors: Darell D. Bigner Henry S. Friedman Roger E. McLendon Allan H. Friedman Sandra H. Bigner Surinder K. Batra Michael R. Zalutsky Chien‐Tsun Kuan
Cited by: Genetics Oncology Immunology and Allergy
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (4 papers)
Partner nations: United States Sweden Switzerland

In The Last Decade

Carol J. Wikstrand

105 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Carol J. Wikstrand

Since Specialization

Citations

This map shows the geographic impact of Carol J. Wikstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol J. Wikstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol J. Wikstrand more than expected).

Fields of papers citing papers by Carol J. Wikstrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol J. Wikstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol J. Wikstrand. The network helps show where Carol J. Wikstrand may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carol J. Wikstrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carol J. Wikstrand Line = papers co-authored together Carol J. Wikstrand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy Clinical Cancer Research ·Vidyalakshmi Chandramohan,Xuhui Bao,Stephen T. Keir,Charles N. Pegram,Scott E. Szafranski,Hailan Piao,Carol J. Wikstrand,Roger E. McLendon,Chien‐Tsun Kuan,Ira Pastan,Darell D. Bigner	2013	58
2	Detection of Amino-terminal Extracellular Domain of Somatostatin Receptor 2 by Specific Monoclonal Antibodies and Quantification of Receptor Density in Medulloblastoma Hybridoma ·Chien‐Tsun Kuan,Carol J. Wikstrand,Roger E. McLendon,Michael R. Zalutsky,Ujendra Kumar,Darell D. Bigner	2009	5
3	Immune Responses of Breast Cancer Patients to Mutated Epidermal Growth Factor Receptor (EGF-RvIII, ΔEGF-R, and de2–7 EGF-R) The Journal of Immunology ·Enkhtsetseg Purev,Dewei Cai,Eric P. Miller,Rolf Swoboda,Ted Mayer,Andres J. Klein–Szanto,Francesco M. Marincola,Rosemarie Mick,László Ötvös,William H. Wunner,Brigitte Birebent,Rajasekharan Somasundaram,Carol J. Wikstrand,Darell D. Bigner,Angela DeMichele,Géza Ács,Jesse A. Berlin,Dorothee Herlyn	2004	26
4	Monoclonal antibodies for brain tumour treatment Expert Opinion on Biological Therapy ·Abraham Boskovitz,Carol J. Wikstrand,Chien‐Tsun Kuan,Michael R. Zalutsky,David A. Reardon,Darell D. Bigner	2004	37
5	Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system Cancer Immunology Immunotherapy ·Carol J. Wikstrand,Vanessa R. Cole,Laura E. Crotty Alexander,John H. Sampson,Darell D. Bigner	2002	18
6	EGF mutant receptor vIII as a molecular target in cancer therapy. Endocrine Related Cancer ·Chien‐Tsun Kuan,Carol J. Wikstrand,Darell D. Bigner	2001	247
7	EGFRvIII as a promising target for antibody-based brain tumor therapy Brain Tumor Pathology ·Chien‐Tsun Kuan,Carol J. Wikstrand,Darell D. Bigner	2000	42
8	In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line Glycoconjugate Journal ·Pam Fredman,Carol J. Wikstrand,J. -E. M�nsson,Guido Reifenberger,S H Bigner,Ahmed Muhei Rasheed,Lars Svennerholm,Darell D. Bigner	1996	7
9	Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report Journal of Neuro-Oncology ·Darell D. Bigner,M. Brown,R. Edward Coleman,Allan H. Friedman,Henry S. Friedman,Roger E. McLendon,Sandra H. Bigner,Xiao Guang Zhao,Carol J. Wikstrand,Charles N. Pegram,Tracy Kerby,Michael R. Zalutsky	1995	96
10	Tumor antigens in astrocytic gliomas Glia ·Shekar N. Kurpad,Xiaoguang Zhao,Carol J. Wikstrand,Surinder K. Batra,Roger E. McLendon,Darell D. Bigner	1995	92
11	Mouse/Human Chimeric Me1-14 Antibody: Genomic Cloning of the Variable Region Genes, Linkage to Human Constant Region Genes, Expression, and Characterization Hybridoma ·Surinder K. Batra,Maria L. Niswonger,Carol J. Wikstrand,Charles N. Pegram,Michael R. Zalutsky,Sherie L. Morrison,Darell D. Bigner	1994	14
12	Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy Journal of Neuro-Oncology ·Dennis F. Deen,Andrew Chiarodo,Elizabeth A. Grimm,John R. Fike,Mark A. Israel,Lawrence E. Kun,Victor A. Levin,Laurence J. Marton,Roger J. Packer,Anthony E. Pegg,Mark L. Rosenblum,Herman D. Suit,Michael Walker,Carol J. Wikstrand,Charles B. Wilson,Albert J. Wong,W.K. Alfred Yung	1993	47
13	Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas Journal of Neuroimmunology ·Carol J. Wikstrand,Sydney Stanley,Peter A. Humphrey,Charles N. Pegram,Gerald E. Archer,Shekar N. Kurpad,Masabumi Shibuya,Darell D. Bigner	1993	24
14	Monoclonal antibodies to malignant human gliomas Molecular and Chemical Neuropathology ·Carol J. Wikstrand,Pam Fredman,Lars Svennerholm,Peter A. Humphrey,Sandra H. Bigner,Darell D. Bigner	1992	13
15	Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas Acta Neuropathologica ·D. C. Longee,Carol J. Wikstrand,J. -E. M�nsson,X. He,Gregory N. Fuller,Sandra H. Bigner,Pam Fredman,Lars Svennerholm,D D Bigner	1991	48
16	Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Pam Fredman,Jan‐Eric Månsson,Sandra H. Bigner,Carol J. Wikstrand,Darell D. Bigner,Lars Svennerholm	1990	36
17	Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2 Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·G B Karlsson,Jan‐Eric Månsson,Carol J. Wikstrand,Darell D. Bigner,Lars Svennerholm	1990	19
18	GD3 expression by cultured human tumor cells of neuroectodermal origin Acta Neuropathologica ·X. He,Carol J. Wikstrand,Pam Fredman,J. -E. M�nsson,Lars Svennerholm,Darell D. Bigner	1989	26
19	Phenotypic Analysis of Four Human Medulloblastoma Cell Lines and Transplantable Xenografts Journal of Neuropathology & Experimental Neurology ·Xuanmin He,Stephen X. Skapek,Carol J. Wikstrand,Henry S. Friedman,John Q. Trojanowski,John T. Kemshead,Hugh B. Coakham,Sandra H. Bigner,Darell D. Bigner	1989	74
20	Ganglioside mapping of a human medulloblastoma xenograft Acta Neuropathologica ·Johan Gottfries,Jan‐Eric Månsson,Pam Fredman,Carol J. Wikstrand,Henry S. Friedman,Darell D. Bigner,Lars Svennerholm	1989	8

About Carol J. Wikstrand

Carol J. Wikstrand is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Immunology, having authored 105 papers that have together received 7.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (39 papers), Radiopharmaceutical Chemistry and Applications (28 papers), Glycosylation and Glycoproteins Research (26 papers), Neuroblastoma Research and Treatments (24 papers), Immunotherapy and Immune Responses (18 papers), Glioma Diagnosis and Treatment (17 papers), HER2/EGFR in Cancer Research (13 papers) and Cell Adhesion Molecules Research (11 papers). The work is most often cited by research in Genetics (2.0k citations), Oncology (2.7k citations) and Immunology and Allergy (532 citations). Carol J. Wikstrand has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include Darell D. Bigner, Henry S. Friedman, Roger E. McLendon, Allan H. Friedman, Sandra H. Bigner, Surinder K. Batra, Michael R. Zalutsky, Chien‐Tsun Kuan, Charles N. Pegram and Gary E. Archer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact